Advanced Solid Tumors: Anti-GD2 ADC M3554

We are testing a new treatment for patients with advanced solid tumors to see if it can improve their condition. This study aims to evaluate the safety and effectiveness of the drug.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
General Medical Oncology
Heverlee, Belgium
Institut Bergonie
Oncologie médicale
Bordeaux, France
Centre Oscar Lambret
Oncologie médicale
Loos, France

Sponsor: Merck Healthcare KGaA
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.